Sustainability of Biobanks in the Future.

Human biorepositories are essential in providing high quality specimens that are well characterized. Biospecimens are used in basic, clinical, and translational research. However, as regulatory requirements and scientific demands increase the complexity of the daily operations of a biorepository, the cost of maintaining a biobank will increase. How can biobanks today maintain sustainability during the current economic climate and changing landscape of operating a biorepository? This is a brief review of how different biobanks have approached sustainability.

[1]  C. Compton,et al.  Biobankonomics: a taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research. , 2011, Journal of the National Cancer Institute. Monographs.

[2]  Helen M. Moore,et al.  An NCI perspective on creating sustainable biospecimen resources. , 2011, Journal of the National Cancer Institute. Monographs.

[3]  C. Compton,et al.  Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. , 2011, Journal of the National Cancer Institute. Monographs.

[4]  Akihiro Miyazaki,et al.  Journal of Translational Medicine Comparative Study on the Immunogenicity between an Hla-a24-restricted Cytotoxic T-cell Epitope Derived from Survivin and That from Its Splice Variant Survivin-2b in Oral Cancer Patients , 2009 .

[5]  SchacterBrent,et al.  A Practical Tool for Modeling Biospecimen User Fees , 2014 .

[6]  J. Greenspan,et al.  Biobanking past, present and future: responsibilities and benefits. , 2013, AIDS.

[7]  Kathi Shea,et al.  Development of external quality assurance programs for biorepositories. , 2012, Biopreservation and biobanking.

[8]  Jim Vaught,et al.  A review of international biobanks and networks: success factors and key benchmarks. , 2009, Biopreservation and biobanking.

[9]  Sandra A. McDonald,et al.  Fee-for-service as a business model of growing importance: the academic biobank experience. , 2012, Biopreservation and biobanking.

[10]  Jane E. Carpenter,et al.  A framework for biobank sustainability. , 2014, Biopreservation and biobanking.

[11]  Angen Liu.  Developing an institutional cancer biorepository for personalized medicine. , 2014, Clinical biochemistry.

[12]  Bridging the financial gap through providing contract services: a model for publicly funded clinical biobanks. , 2012, Biopreservation and biobanking.

[13]  D. Winickoff,et al.  The charitable trust as a model for genomic biobanks. , 2003, The New England journal of medicine.

[14]  Karen E Pitt,et al.  Development of a global certification program for biorepository technical professionals. , 2012, Biopreservation and biobanking.

[15]  I. Biunno,et al.  Comprehensive outsourcing biobanking facility to serve the international research community. , 2011, Biopreservation and biobanking.

[16]  M. Murtagh,et al.  Biobank Economics and the Commercialization Problem , 2013 .

[17]  Katherine C Sexton,et al.  Development of the ISBER Best Practices for Repositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research. , 2012, Biopreservation and biobanking.

[18]  M. McQueen,et al.  The challenge of establishing, growing and sustaining a large biobank: a personal perspective. , 2014, Clinical biochemistry.